240EGP
- Active ingredient
- asparaginase(l-asparaginase)
- Strength
- 10000 i.u.
- Form
- vial
- Manufacturer
- opi-france > medico pharma
- Route
- injection
Uses
Used as part of combination chemotherapy regimens for acute lymphoblastic leukemia and certain lymphoid malignancies.
Do not use if
Contraindicated in patients with severe hypersensitivity to asparaginase or a history of serious pancreatitis related to treatment.
Side effects
May cause hypersensitivity reactions, pancreatitis, liver dysfunction, hyperglycemia, and coagulation abnormalities.
Warnings
Requires close monitoring of liver function, coagulation parameters, glucose levels, and signs of pancreatitis.
How it works
Hydrolyzes circulating asparagine, depriving susceptible cancer cells of an essential amino acid required for protein synthesis.
Storage
Store according to manufacturer recommendations, usually refrigerated and protected from light.